Source:http://linkedlifedata.com/resource/pubmed/id/17002283
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
39
|
pubmed:dateCreated |
2006-9-27
|
pubmed:abstractText |
Coronavirus nucleocapsid (N) protein envelops the genomic RNA to form long helical nucleocapsid during virion assembly. Since N protein oligomerization is usually a crucial step in this process, characterization of such an oligomerization will help in the understanding of the possible mechanisms for nucleocapsid formation. The N protein of severe acute respiratory syndrome coronavirus (SARS-CoV) was recently discovered to self-associate by its carboxyl terminus. In this study, to further address the detailed understanding of the association feature of this C-terminus, its oligomerization was systematically investigated by size exclusion chromatography and chemical cross-linking assays. Our results clearly indicated that the C-terminal domain of SARS-CoV N protein could form not only dimers but also trimers, tetramers, and hexamers. Further analyses against six deletion mutants showed that residues 343-402 were necessary and sufficient for this C-terminus oligomerization. Although this segment contains many charged residues, differences in ionic strength have no effects on its oligomerization, indicating the absence of electrostatic force in SARS-CoV N protein C-terminus self-association. Gel shift assay results revealed that the SARS-CoV N protein C-terminus is also able to associate with nucleic acids and residues 363-382 are the responsible interaction partner, demonstrating that this fragment might involve genomic RNA binding sites. The fact that nucleic acid binding could promote the SARS-CoV N protein C-terminus to form high-order oligomers implies that the oligomeric SARS-CoV N protein probably combines with the viral genomic RNA in triggering long nucleocapsid formation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-2960
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
11827-35
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17002283-Amino Acid Sequence,
pubmed-meshheading:17002283-Binding Sites,
pubmed-meshheading:17002283-Chromatography, Gel,
pubmed-meshheading:17002283-Dimerization,
pubmed-meshheading:17002283-Genome, Viral,
pubmed-meshheading:17002283-Nucleocapsid,
pubmed-meshheading:17002283-Nucleocapsid Proteins,
pubmed-meshheading:17002283-Protein Binding,
pubmed-meshheading:17002283-Protein Structure, Tertiary,
pubmed-meshheading:17002283-RNA, Viral,
pubmed-meshheading:17002283-SARS Virus,
pubmed-meshheading:17002283-Sequence Deletion,
pubmed-meshheading:17002283-Static Electricity,
pubmed-meshheading:17002283-Virus Assembly
|
pubmed:year |
2006
|
pubmed:articleTitle |
Carboxyl terminus of severe acute respiratory syndrome coronavirus nucleocapsid protein: self-association analysis and nucleic acid binding characterization.
|
pubmed:affiliation |
Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|